Xilio Therapeutics (XLO) Institutional Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free XLO Stock Alerts $1.06 +0.05 (+4.95%) (As of 12:32 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Xilio Therapeutics (NASDAQ:XLO)CurrentInstitutional OwnershipPercentage54.29%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$32.40KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$293.43K Get XLO Insider Trade Alerts Want to know when executives and insiders are buying or selling Xilio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data XLO Institutional Buying and Selling by Quarter Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << Xilio Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/22/2024 PFG Investments LLC30,000$32K0.0%N/A0.087% 2/15/2024Octagon Capital Advisors LP1,785,000$982K0.2%-23.0%6.481% 11/14/2022Ergoteles LLC12,941$38K0.0%-26.3%0.047% 8/15/2022Laurion Capital Management LP142,900$417K0.0%N/A0.520% 7/27/2022Bailard Inc.36,632$107K0.0%N/A0.133% 5/16/2022Deerfield Management Company L.P. Series C2,078,692$14.70M0.3%-3.5%7.567% 5/12/2022Monashee Investment Management LLC163,066$1.15M0.3%-23.9%0.594% 2/15/2022Davidson Kempner Capital Management LP29,000$458K0.0%N/A0.109% 2/14/2022Deerfield Management Company L.P. Series C2,154,061$33.74M0.7%N/A8.078% 2/14/2022Ghisallo Capital Management LLC30,000$480K0.0%N/A0.113% 2/14/2022Soleus Capital Management L.P.477,495$7.64M0.8%N/A1.791% 2/11/2022Granite Point Capital Management L.P.10,000$160K0.0%N/A0.038% 2/9/2022AJU IB Investment Co. Ltd.667,742$10.68M14.9%N/A2.504% 2/8/2022Northern Trust Corp63,034$1.01M0.0%N/A0.236% 2/7/2022Monashee Investment Management LLC214,253$3.43M0.8%N/A0.803% 2/7/2022RiverVest Venture Management LLC1,441,444$23.06M16.5%N/A5.406% 2/2/2022New York State Common Retirement Fund5,568$89K0.0%N/A0.021% (Data available from 1/1/2016 forward) XLO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of XLO shares? During the previous two years, the following institutional investors and hedge funds held shares of Xilio Therapeutics shares: Deerfield Management Company L.P. Series C ($14.70M), Monashee Investment Management LLC ($1.15M), Octagon Capital Advisors LP ($982K), Laurion Capital Management LP ($417K), Bailard Inc. ($107K), and Ergoteles LLC ($38K), and PFG Investments LLC ($32K).Learn more on XLO's institutional investors. What percentage of Xilio Therapeutics stock is owned by institutional investors? 54.29% of Xilio Therapeutics stock is owned by institutional investors. Learn more on XLO's institutional investor holdings. Which institutional investors have been buying Xilio Therapeutics stock? The following institutional investors have purchased Xilio Therapeutics stock in the last 24 months: Laurion Capital Management LP ($142.90K), Bailard Inc. ($36.63K), and PFG Investments LLC ($30K). How much institutional buying is happening at Xilio Therapeutics? Institutional investors have bought a total of 209,532 shares in the last 24 months. This purchase volume represents approximately $556.63K in transactions. Which Xilio Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Xilio Therapeutics stock in the last 24 months: Octagon Capital Advisors LP ($533.50K), Deerfield Management Company L.P. Series C ($75.37K), Monashee Investment Management LLC ($51.19K), and Ergoteles LLC ($4.61K). How much institutional selling is happening at Xilio Therapeutics? Institutional investors have sold a total of 664,663 shares in the last 24 months. This volume of shares sold represents approximately $1.20M in transactions. Related Companies: AADI Institutional Ownership NXTC Institutional Ownership BOLT Institutional Ownership RMTI Institutional Ownership OCUP Institutional Ownership CALC Institutional Ownership APLM Institutional Ownership NRXP Institutional Ownership DARE Institutional Ownership JAGX Institutional Ownership This page (NASDAQ:XLO) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xilio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
